These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15211734)

  • 1. [Homocysteine and cardiovascular risk].
    Mazza A; Bossone E; Mazza F; Distante A
    Monaldi Arch Chest Dis; 2004 Mar; 62(1):29-33. PubMed ID: 15211734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine and risk of cardiovascular disease.
    Andreotti F; Burzotta F; Manzoli A; Robinson K
    J Thromb Thrombolysis; 2000 Jan; 9(1):13-21. PubMed ID: 10590184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine and arterial occlusive disease: a concise review.
    Andreotti F; Burzotta F; Mazza A; Manzoli A; Robinson K; Maseri A
    Cardiologia; 1999 Apr; 44(4):341-5. PubMed ID: 10371785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients.
    Fellah H; Feki M; Hsairi M; Sanhaji H; Kaabachi N; Ben Abdallah T; Massy ZA; Ben Maiz H; Lacour B; Mebazaa A
    Clin Chem Lab Med; 2003 May; 41(5):675-80. PubMed ID: 12812266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total serum homocysteine, folate and vitamin B12 in a Greek school age population.
    Papandreou D; Mavromichalis I; Makedou A; Rousso I; Arvanitidou M
    Clin Nutr; 2006 Oct; 25(5):797-802. PubMed ID: 16690175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine, folate, and cardiovascular disease.
    Ward M
    Int J Vitam Nutr Res; 2001 May; 71(3):173-8. PubMed ID: 11582839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years.
    Wolters M; Hermann S; Hahn A
    Eur J Nutr; 2005 Mar; 44(3):183-92. PubMed ID: 15309436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine and atherothrombosis.
    Falk E; Zhou J; Møller J
    Lipids; 2001; 36 Suppl():S3-11. PubMed ID: 11837989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of some of the cardiovascular risk factors in vegetarian and omnivorous Turkish females.
    Karabudak E; Kiziltan G; Cigerim N
    J Hum Nutr Diet; 2008 Feb; 21(1):13-22. PubMed ID: 18184390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine, traditional risk factors and impaired renal function in coronary artery disease.
    Pizzolo F; Friso S; Olivieri O; Martinelli N; Bozzini C; Guarini P; Trabetti E; Faccini G; Corrocher R; Girelli D
    Eur J Clin Invest; 2006 Oct; 36(10):698-704. PubMed ID: 16968465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V; Kes P; Reiner Z
    Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma ω-3 fatty acid levels negatively and ω-6 fatty acid levels positively associated with other cardiovascular risk factors including homocysteine in severe obese subjects.
    Mehmetoglu I; Yerlikaya FH; Kurban S; Polat H
    Asia Pac J Clin Nutr; 2012; 21(4):519-25. PubMed ID: 23017310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group.
    Verhoef P; Meleady R; Daly LE; Graham IM; Robinson K; Boers GH
    Eur Heart J; 1999 Sep; 20(17):1234-44. PubMed ID: 10454975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease.
    Suliman ME; Lindholm B; Bárány P; Bergström J
    Clin Chem Lab Med; 2001 Aug; 39(8):734-8. PubMed ID: 11592443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease.
    De Bree A; Verschuren WM; Kromhout D; Kluijtmans LA; Blom HJ
    Pharmacol Rev; 2002 Dec; 54(4):599-618. PubMed ID: 12429870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous carriers of classical homocystinuria tend to have higher fasting serum homocysteine concentrations than non-carriers in the presence of folate deficiency.
    Lu YH; Cheng LM; Huang YH; Lo MY; Wu TJ; Lin HY; Hsu TR; Niu DM
    Clin Nutr; 2015 Dec; 34(6):1155-8. PubMed ID: 25516282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
    Booth GL; Wang EE
    CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Homocysteine--a routine biochemical parameter in cardiovascular diseases?].
    Gábor D; Hrnciar J; Hricová I; Zacharová M
    Vnitr Lek; 1999 Jan; 45(1):40-5. PubMed ID: 10422525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.